Aidence vs Kepler Vision
In-depth comparison — valuation, funding, investors, founders & more
🇳🇱 Netherlands · Jeroen Vendrig
Valuation
N/A
Total Funding
$20M
1-50 employees
🇳🇱 Netherlands · Harro Stokman
Valuation
N/A
Total Funding
N/A
1-50 employees
Analyst Summary
Generated from real data · No AI hallucinations
Both Aidence and Kepler Vision compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Aidence develops AI radiology software for lung cancer detection, building CE-marked and FDA-cleared deep learning algorithms that analyse CT scan images to identify and characterise pulmonary nodules requiring clinical follow-up. Kepler Vision Technologies develops AI fall detection and activity recognition software for elderly care environments, using computer vision models that process video from ceiling-mounted cameras in care facilities to detect falls, assess resident activity patterns, and alert care staff to incidents requiring immediate response.
Neither company has publicly disclosed a valuation at this time. Aidence has raised $20M in disclosed funding.
Aidence has 1 year more market experience, having been founded in 2016 compared to Kepler Vision's 2017 founding. In terms of growth stage, Aidence is at Series B while Kepler Vision is at Seed — a meaningful difference for investors evaluating risk and upside.
Both companies are headquartered in 🇳🇱 Netherlands, competing for the same regional talent and customer base. On Awaira's 0–100 composite score, Aidence leads with a score of 45, reflecting stronger overall fundamentals across valuation, funding, and growth signals.
Metrics Comparison
| Metric | Aidence | Kepler Vision |
|---|---|---|
💰Valuation | N/A | N/A |
📈Total Funding | $20M | N/A |
📅Founded | 2016 | 2017WINS |
🚀Stage | Series B | Seed |
👥Employees | 1-50 | 1-50 |
🌍Country | Netherlands | Netherlands |
🏷️Category | AI Healthcare | AI Healthcare |
⭐Awaira Score | 45WINS | 30 |
Key Differences
Market experience: Aidence has 1 year more (founded 2016 vs 2017)
Growth stage: Aidence is at Series B vs Kepler Vision at Seed
Direct competitors: Both operate in the AI Healthcare market segment
Awaira Score: Aidence scores 45/100 vs Kepler Vision's 30/100
Which Should You Choose?
Use these signals to make the right call
Choose Aidence if…
Top Pick- ✓Higher Awaira Score — 45/100 vs 30/100
- ✓Stronger investor backing — raised $20M
- ✓More market experience — founded in 2016
- ✓Aidence develops AI radiology software for lung cancer detection, building CE-marked and FDA-cleared deep learning algorithms that analyse CT scan images to identify and characterise pulmonary nodules requiring clinical follow-up
Choose Kepler Vision if…
- ✓Kepler Vision Technologies develops AI fall detection and activity recognition software for elderly care environments, using computer vision models that process video from ceiling-mounted cameras in care facilities to detect falls, assess resident activity patterns, and alert care staff to incidents requiring immediate response